ICUI
$190.35
I C U Medical
($1.07)
(.56%)
ICUI
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.10
Revenue:  $280.60 Mil
Thursday
Nov 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ICUI reports earnings?
Beat
Meet
Miss

Where is ICUI's stock price going from here?
Up
Flat
Down
Stock chart of ICUI
Analysts
Summary of analysts' recommendations for ICUI
Score
Grade
Pivots
Resistance
$207.98
$204.21
$197.82

$194.05

Support
$187.66
$183.89
$177.50
Tweet
Growth
Description
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWatersTeleflexIntegra LifeSciences HoldingsCardiovascular Systems3M